| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |
| 02/17/2005 | US20050038045 A2B adenosine receptor antagonists |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050037494 Using antisense agents to reduce and/or prevention genic expression associated with cardi-vascular complications; gene therapy |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037074 Treating adrenal dysfunction in a patient by administering a pharmaceutically effective amount of a combined glucocorticoid such as hydrocortisone and a delivery vehicle, wherein delivery vehicle provides for delayed and sustained release of glucorticoid; congenital adrenal hyperplasia |
| 02/17/2005 | US20050037028 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | US20050036951 Methods of treating lung diseases |
| 02/17/2005 | US20050036949 A pharmaceutical dispenser; a liquid formulation comprising nitric oxide; respiratory system diseases; atomizing |
| 02/17/2005 | US20050036943 Methods and compositions for the diagnosis of asthma |
| 02/17/2005 | DE202004015396U1 Mixture of oregano oil and lanolin, useful for control of methicillin-resistant Staphylococcus aureus on skin and in the nose |
| 02/17/2005 | CA2535125A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2535066A1 Macrophage activation inhibitor |
| 02/17/2005 | CA2534934A1 Advantageous combinations for inhalation of nacystelyn and bronchodilators |
| 02/17/2005 | CA2534905A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | CA2534693A1 Medicaments for inhalation comprising steroids and a betamimetic |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534415A1 Therapeutic delivery of carbon monoxide |
| 02/17/2005 | CA2534125A1 Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders |
| 02/17/2005 | CA2533786A1 Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
| 02/16/2005 | EP1506999A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 02/16/2005 | EP1506958A1 Process for producing shogaol and intermediates for the synthesis thereof |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 02/16/2005 | EP1506234A1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 02/16/2005 | EP1506214A1 6-11 bicyclic ketolide derivatives |
| 02/16/2005 | EP1506205A2 Novel azacyclic ethynyl derivatives |
| 02/16/2005 | EP1506204A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 02/16/2005 | EP1506202A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof |
| 02/16/2005 | EP1506200A2 Novel diazabicyclic biaryl derivatives |
| 02/16/2005 | EP1506198A1 5-ethylimidarotriazones |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506191A1 Benzoxazine and benzoxazinone substituted triazoles |
| 02/16/2005 | EP1506187A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1506167A1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506162A2 Synthesis of benzonitriles and benzimidates |
| 02/16/2005 | EP1506040A2 Selective inos inhibitors for the treatment of respiratory diseases and conditions |
| 02/16/2005 | EP1506016A2 New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1506007A2 Mucosal combination vaccines for bacterial meningitis |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1505975A1 Compositions and method for treating infection in cattle and swine |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505972A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505957A1 Matrix type patch containing bronchodilators |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582288A Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1582158A Novel therapeutic indication of azithromycin for treatment of non-infective inflammatory diseases |
| 02/16/2005 | CN1580261A CC10 protein preparation and use |
| 02/16/2005 | CN1580077A Echinacea polysaccharide, and its preparing method and use for preparing medicines for treating antivirus and antibacterial, especially anti SARS |
| 02/16/2005 | CN1580073A Human SARS virus surface film protein antigen determinant polypeptide, polynucleotide sequence and its use |
| 02/16/2005 | CN1579548A Use of Hepatitis vaccine for preventing and treating series acute repiratory tract syndrome |
| 02/16/2005 | CN1579545A Use of regenerated human interferon beta-1b for preparing medicine to prevent and treat SARS |
| 02/16/2005 | CN1579528A Soft capsule of expelling toxin by cooling and its preparation method |
| 02/16/2005 | CN1579513A Compound throat sucking-tablet of semen sterculiae scaphigerae and oral tonic thereof |
| 02/16/2005 | CN1579498A Asthma-relieving liquor and its preparation process |
| 02/16/2005 | CN1579489A Traditional Chinese medicinal composition for treating coronary heart disease and its preparation method |
| 02/16/2005 | CN1579474A Medicinal composition, its preparation method and use |
| 02/16/2005 | CN1579467A Anti-virus medicine |
| 02/16/2005 | CN1579460A External-applying treating liquid for rhinitis and common cold, and its preparation method thereof |
| 02/16/2005 | CN1579451A South Radix-Isatidis soft capsule and preparation method |
| 02/16/2005 | CN1579441A Cough-relieving medicine and its preparation method |
| 02/16/2005 | CN1579421A Freeze-dried powder of pig's lung surface matter, its preparation method and use |
| 02/16/2005 | CN1579404A Novel preparation of glycyrrhizin |
| 02/16/2005 | CN1579401A Cought and asthma relieaving preparation and its preparation method |
| 02/16/2005 | CN1579382A New decanoy-acetaldehyde sodium infusion and its preparation process |
| 02/16/2005 | CN1579381A Decanoy-acetaldehyde sodium for injection and its preparation process |
| 02/16/2005 | CN1579380A Decanoy-acetaldehyde sodium frozen-dry powder injecta and preparation method |
| 02/16/2005 | CN1579377A Use of Rhizoma-Curcumae-Longae element in preparing medicine for treating lung disease |
| 02/16/2005 | CN1579375A Garlic element fat emulsion and its preparation process |
| 02/16/2005 | CN1579264A Method for making cigarette to treat, prevent and health-care respiratory system disease |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189199C Oral liquid for treating cough and asthma |
| 02/16/2005 | CN1189195C Medicine for curing cough and asthma |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855706 Phenylalanine derivatives |